CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding

Author:

Ackloo Suzanne12,Al-awar Rima31,Amaro Rommie E.4,Arrowsmith Cheryl H.12,Azevedo Hatylas5,Batey Robert A.1,Bengio Yoshua6,Betz Ulrich A.K.7,Bologa Cristian G.8,Chodera John D.9,Cornell Wendy D.10,Dunham Ian11,Ecker Gerhard F.12,Edfeldt Kristina13ORCID,Edwards Aled M.21,Gilson Michael K.4,Gordijo Claudia R.21,Hessler Gerhard14,Hillisch Alexander15,Hogner Anders16,Irwin John J.17,Jansen Johanna M.18,Kuhn Daniel7,Leach Andrew R.11,Lee Alpha A.1920,Lessel Uta21,Moult John2223,Muegge Ingo24,Oprea Tudor I.25,Perry Benjamin G.26,Riley Patrick27,Saikatendu Kumar Singh28,Santhakumar Vijayaratnam21,Schapira Matthieu21,Scholten Cora15,Todd Matthew H.29,Vedadi Masoud21,Volkamer Andrea30,Willson Timothy M.31

Affiliation:

1. University of Toronto

2. Structural Genomics Consortium

3. Ontario Institute for Cancer Research

4. University of California, San Diego

5. Aché Laboratórios Farmacêuticos

6. University of Montreal

7. Merck Healthcare KGaA

8. University of New Mexico Albuquerque

9. Memorial Sloan Kettering Cancer Center

10. IBM TJ Watson Research Center

11. European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI)

12. University of Vienna

13. Karolinska Institute

14. Sanofi-Aventis Deutschland GmbH

15. Bayer AG, Pharmaceuticals

16. AstraZeneca (Sweden)

17. University of California, San Francisco

18. Novartis Institutes for BioMedical Research

19. PostEra Inc.

20. University of Cambridge

21. Boehringer Ingelheim Pharma GmbH & Co. KG

22. Institute for Bioscience and Biotechnology Research

23. University of Maryland, College Park

24. Alkermes, Inc.

25. University of New Mexico School of Medicine

26. Drugs for Neglected Diseases Initiative

27. Relay Therapeutics

28. Takeda California, Inc.

29. University College London

30. Charité - University Medicine Berlin

31. University of North Carolina at Chapel Hill

Abstract

Computational approaches in drug discovery and development hold great promise, with artificial intelligence methods undergoing widespread contemporary use, but the experimental validation of these new approaches is frequently inadequate. We are initiating Critical Assessment of Computational Hit-finding Experiments (CACHE) as a public benchmarking project that aims to accelerate the development of small molecule hit-finding algorithms by competitive assessment. Compounds will be identified by participants using a wide range of computational methods for dozens of protein targets selected for different types of prediction scenarios, as well as for their potential biological or pharmaceutical relevance. Community-generated predictions will be tested centrally and rigorously in an experimental hub(s), and all data, including the chemical structures of experimentally tested compounds, will be made publicly available without restrictions. The ability of a range of computational approaches to find novel compounds will be evaluated, compared, and published. The overarching goal of CACHE is to accelerate the development of computational chemistry methods by providing rapid and unbiased feedback to those developing methods, with an ancillary and valuable benefit of identifying new compound-protein binding pairs for biologically interesting targets. The initiative builds on the power of crowd sourcing and expands the open science paradigm for drug discovery.

Publisher

Cambridge University Press (CUP)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3